Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus tizanidine as adjuncts to methadone for opioid withdrawal syndrome
IRCT20210213050348N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of clonidine, tizanidine and methadone in opioid withdrawal (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Objective Opioid Withdrawal Scale score and Sedation level. Started Mar 2021; status: completed.
02
Drugs
clonidinetizanidinemethadone
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on IRCT20210213050348N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210213050348N1.